Transcript Highlights:

• Brian and the vets program, uh, to, to make sure that Texas is the one who leads on this and we see FDA

Transcript Highlights:

• is off label in the U.S., which means for a condition other than the one it was approved for by the FDA
• :43.360> the than the one it was approved for by the than the one it was approved for by the FDA
• 44.480> least<00:03:44.879> 10<00:03:45.280> other<00:03:45.599> medical FDA
• and at least 10 other medical FDA and at least 10 other medical cannabis<00:03:46.400> states

Keywords: 912, senate, all

Summary: The committee heard testimony on HB 302, which would expand access to medical cannabis by removing the in-person provider-patient relationship requirement and related restrictions. The Department of Health supported the bill, and multiple advocates and organizations testified in support, including the ACLU of Hawaii, Hawaii Alliance for Cannabis Reform, Marijuana Policy Project, and others. Supporters said the measure would improve access for patients, especially on outer islands, and some urged broader amendments allowing providers to certify cannabis for any medical condition and to speed registration and treat in-state and out-of-state patients equally. No opposition was heard, and the bill was left with no questions after testimony. The committee also heard HB 1052 HD1, which clarifies that the Public Utilities Commission may use universal service fund monies to provide free telecommunications access for individuals with print disabilities. Testimony was uniformly supportive from the DCCA Division of Consumer Advocacy, the State Council on Developmental Disabilities, the Department of Human Services, the Public Utilities Commission, and the National Federation of the Blind of Hawaii. Witnesses described the program as an important accessibility service that has been operating under prior appropriations and should continue under the universal service program. HB 1482, relating to controlled substances and hemp/synthetic cannabinoids, drew support from the Department of Law Enforcement, Department of Health, Honolulu Police Department, and others, with some comments from the Attorney General’s office. Supporters said the bill would clarify that delta-8 THC is a controlled substance and help enforcement against illegal hemp products and synthetic cannabinoids. Testimony and questioning focused on the need for better lab testing capacity, retail registry and age-gating, seizure authority, nuisance abatement, and possible use of special funds or appropriations to support enforcement. Members also discussed enforcement of illegal hemp businesses and whether additional funding or statutory changes would be needed. Finally, the committee took up HB 712, a 340B drug-discount measure affecting safety-net providers and contract pharmacies. Hospitals, health centers, and provider groups testified in support, saying the bill would protect access to discounted drugs and preserve funding for services such as chronic disease management, transportation, and specialty care. Pharmaceutical-industry representatives opposed the bill or sought amendments, arguing the 340B program has expanded beyond its original intent and lacks transparency, and they requested reporting or audit-like provisions to verify claims and revenues. Members questioned both sides about alleged abuse, the growth of contract pharmacies, and whether the bill should include transparency requirements before moving forward.

Transcript Highlights:

• little to no hope for families facing this disease, and now we have two treatments approved by the FDA
• The successful trial led to FDA approval of not only this drug, but also new lower-cost methods of diagnosis

Bills: HB2050, HB2082, HB2176, HB2195, HB2202, HB2307, HB2584

Keywords: radiologic technologist, radiologist assistant, radiology, imaging, x-ray, diagnostic x-ray, fluoroscopy, mammography, computed tomography, CT technologist, nuclear medicine technologist, bone densitometry, radiation safety, radiation licensing, scope of practice, health workforce, rural health care, critical access hospital, supervision, telehealth

Summary: The committee approved the minutes and then heard House Bill 2050, which updates Department of Health Services rules for radiologic technologists and radiologic assistants. The bill changes school accreditation and training requirements, reduces clinical hours, revises supervision and scope-of-practice rules, adjusts fees, and removes radiologic technologists from the telehealth health care provider definition. Testimony from a radiologic technologist supported the bill as an update to outdated standards and a response to workforce shortages, while a nurse practitioner supported the section allowing NPs to use diagnostic x-ray machines under nursing board standards. HB 2050 passed 7-0 with a do-pass recommendation. The committee then considered House Bill 2082, which creates a Childhood Cancer and Rare Childhood Disease Research Commission and expands the research fund to include appropriations, gifts, donations, and federal grants. An amendment shifted grant-awarding authority to the DHS director, required the commission to set criteria and review applications, and added public meeting requirements; it also tied funding to at least $5 million in available resources and removed the return-on-investment reporting requirement. Supporters said the bill would strengthen pediatric cancer research and leverage an underused funding source, though members raised concerns about oversight. The bill was amended and then passed 7-0. House Bill 2176 and House Bill 2195 both dealt with DHS licensing and complaint-investigation procedures for health care institutions and nursing care institutions. HB 2176 allows DHS to deny licenses or ownership changes based on serious prior licensing problems or safety risks, and it sets notice, investigation, and deficiency-statement rules; speakers from public health and hospital groups supported it as improving transparency and preventing bad actors from cycling through ownership. HB 2195 limits DHS access to certain personnel records, requires deficiency statements within 10 business days, and bars investigations of incidents older than 12 months; an amendment delayed implementation to July 1, 2027 and added corrective-plan and off-site review provisions. Both bills passed 7-0 as amended. The committee also approved House Bill 2202, which appropriates $300,000 annually for a dementia care tele-mentoring program to train providers statewide, especially in rural and underserved areas. The Alzheimer’s Association and a patient with younger-onset Alzheimer’s testified that the program would improve early diagnosis and care, though one senator opposed state funding on the view that medical schools should teach the material. HB 2202 passed 6-1. Finally, House Bill 2307, addressing placement for dangerous, incompetent, non-restorable defendants when secure state hospital beds are unavailable, drew the most debate. An amendment replaced out-of-state placement with a temporary, limited-use solution involving up to three beds at the Arizona State Hospital forensic campus, created a study committee, and shifted some non-psychiatric costs to counties; counties and hospital stakeholders opposed the county-cost language, while sponsors and DHS said the measure was an emergency stopgap. The amended bill passed 4-3. The committee then passed House Bill 2584 4-3, which prohibits public funds from being used for genetic sequencing equipment from foreign adversary countries or entities; supporters framed it as a national security measure, and opponents voted no. The committee then adjourned.

Transcript Highlights:

• insurance companies, and they already, for opioids, and they already have to do all that reporting to the FDA
• And they already have to do all that reporting to the FDA and to the medical board of when they are prescribing

Bills: SB20, SB111, SB211, SB218, SB14

Keywords: prior authorization, pharmacy benefits manager, PBM, health insurer, prescription drugs, step therapy, formulary, auto-adjudication, electronic portal, appeals, medical necessity, serious mental illness, mental health, schizophrenia, bipolar disorder, major depression, substance use disorder, addiction treatment, cancer, autoimmune disorder

Transcript Highlights:

• This funding will accelerate new drug preparation and FDA. case submissions, compiling data on safety
• being in. able with the support, with your support, to moving these treatments. from clinical trial to FDA

Keywords: 1184, house, all

Transcript Highlights:

• Um, I had done some research as far as with the FDA they had actually lowered the barriers for abortion
• And so there were safety standards that the FDA removed in 2000.
• The FDA approved the drug I think I'm pronouncing this right, myth preone myth preone for chemical abortions
• This is just medication This is just medication abortion: two FDA-approved pills dispensed through a
• campus health center, the same place she goes for a strep test or mental health referral, and access an FDA-approved

Keywords: 981, all

Transcript Highlights:

• We'll begin with Senate Bill 1768, which authorizes Florida license physicians to offer certain FDA of

Transcript Highlights:

• Um, FDA just started doing some regulation, but most of these products are illegal.
• Um, FDA just started doing some regulation, but most of these products are illegal.
• Um, FDA just started doing some regulation, but most of these products are illegal.
• started<00:58:53.119> uh<00:58:53.280> doing<00:58:53.680> some US. um FDA
• just started uh doing some US. um FDA just started uh doing some regulation regulation regulation uh

Bills: HF2779, HF1645, HF1885, HF1289, HF1534, HF2707, HF1675, HF3046

Keywords: health care transparency, ownership disclosure, control reporting, health care consolidation, private equity, management services organization, MSO, provider organization, health insurer, pharmacy benefit manager, hospital system, affiliate reporting, financial disclosure, public reporting, market concentration, horizontal consolidation, vertical consolidation, health care ownership, corporate practice, health care regulation

Transcript Highlights:

• The other program in the bill we added in is FDA-approved nasal spray.
• We're going to say FDA-approved. Okay, I see now where you have it in there as well.
• The other program in the bill we added in is FDA-approved nasal spray.
• We're going to say FDA-approved. Okay, I see now where you have it in there as well.
• We're going to say FDA-approved. Okay, I see now where you have it in there as well.

Keywords: 928, house, all

Summary: The Finance Division 2 hearing took testimony from the director of New Hampshire Police Standards and Training on the agency’s budget request and operations. He described the agency’s role in setting hiring, education, certification, and discipline standards for police, corrections, probation and parole, and court security officers, and noted that the agency runs the full-time, part-time, corrections, and court security training programs. He also outlined the agency’s staffing, facility, and budget request for FY 2026-27, including a request to keep funding level with the governor’s recommendation while shifting funds to support an IT manager position by defunding a vacant administrative slot. The agency requested several statutory changes in Chapter 106, including clarifying the definition of police misconduct, allowing a temporary member on the Conduct Review Committee, clarifying reporting requirements for misconduct allegations, and codifying the Law Enforcement Accreditation Commission. The director also reviewed new responsibilities added in recent years, including crisis intervention training, statewide accreditation, the Conduct Review Committee, and increased annual in-service training requirements. He explained that crisis intervention funding is carried in a continuously appropriated, non-lapsing account and that some budget lines were reclassified, including software and janitorial services, to reflect actual spending needs. Members asked about national standards, the different academy tracks, crisis intervention funding, maintenance and contract changes, temporary positions, and the court security training program. The agency said it coordinates with national peers through IADLEST, that the part-time and corrections academies are longstanding programs, and that the new court security academy can be delivered either as a full academy or as in-service training depending on resources. The director also said the agency has been running extra full-time academies because of high vacancy rates, but expects to return to three full-time academies this year, with two corrections academies and one or possibly two part-time academies. He also explained the current approach to misconduct records and public disclosure, saying sustained findings under RSA 106-L are heard by the council and published, replacing the older, less standardized exculpatory list process.

Transcript Highlights:

• Additionally, FDA-authorized vape products take away a harm reduction tool for adult smokers looking
• Additionally, FDA-authorized vape products take away a harm reduction tool for adult smokers looking
• Additionally, FDA-authorized vape products take away a harm reduction tool for adult smokers looking
• Additionally, FDA-authorized vape products take away a harm reduction tool for adult smokers looking
• "Additionally, FDA-authorized vape products take away a harm reduction tool for adult smokers looking

Keywords: 910, house, all

Summary: The joint Commerce and Consumer Protection and Judiciary and Hawaiian Affairs committees heard HB 756 HD1, a measure on flavored tobacco products. Supporters included the Attorney General, Department of Health, Hawaii State Council on Developmental Disabilities, youth advocates, public health groups, and Kaiser Permanente. They argued flavored tobacco and menthol are used to attract and addict young people, cited rising youth and young adult vaping rates, and pointed to public health harms and evidence from other states that flavor restrictions reduced e-cigarette sales. The Attorney General requested oral amendments to correct a statutory reference, repeal a county preemption provision so counties could enact stricter flavor bans, and restore appropriations, positions, and the original effective date. Opponents, including retail and wholesale businesses, argued the bill would hurt small businesses and state tax revenue, push sales to the black market, and remove a harm-reduction option for adult smokers; they urged stronger enforcement instead of a ban. After testimony, the committees took up amendments and recommendations. The chair proposed correcting the statutory citation to HRS 26-38, adopting a Department of Health amendment on disposal of electronic smoking devices and e-liquids as hazardous waste, and noting the appropriations, FTE, and effective date in the committee report. Members then voted to pass HB 756 HD1 with amendments in both committees, with the Judiciary and Hawaiian Affairs committee recording one member as supporting with reservations. The transcript then moved to HB 806, relating to fireworks, which would appropriate funds for the Department of Law Enforcement to conduct sting operations on Oʻahu to enforce fireworks laws. The Department of Law Enforcement and Honolulu Police Department supported the bill, saying undercover enforcement is costly and additional funding is needed. A community testifier also supported stronger enforcement, citing illegal aerial fireworks, noise, and impacts on pets and kupuna. No final vote on HB 806 was shown in the excerpt. The Judiciary and Hawaiian Affairs committee also heard HB 438, which would create a Due Process in Immigration Proceedings Program to provide legal representation in immigration court for income-qualified individuals. Support came from civil rights, legal aid, ACLU, and law school clinic representatives, who said counsel is needed to ensure due process and fair access to justice, especially because immigration proceedings can lead to deportation and family separation. Opposition testifiers argued taxpayer-funded counsel for people in immigration proceedings is inappropriate, unlawful, or unfair to citizens and legal residents. One law school representative suggested a technical amendment to broaden language about training and education. The excerpt ends before a final vote on HB 438 is shown.

Transcript Highlights:

• So, the FDA has not approved psychedelic therapy for broad-based use.
• Representative Muse: The FDA has not approved psychedelic therapy for broad-based use.
• c> so<05:51:00.400> the<05:51:00.760> the question so the the question so the the FDA
• not<05:51:03.958> approved<05:51:04.680> psychedelic<05:51:05.558> therapy FDA
• Representative Muse: The FDA is not likely to embrace psychedelic therapy anytime soon, mostly because

Keywords: 1189, house, all

Transcript Highlights:

• The FDA does regulate vaping devices under the Tobacco Control Act.
• So I would just suggest looking at that FDA list and incorporating that into this bill.
• But the FDA has a list of e-cigarettes that are authorized by the department.
• But the FDA has a list of e-cigarettes that are authorized by the department.
• But the FDA has a list of e-cigarettes that are authorized by the department.

Keywords: 1189, house, all

Transcript Highlights:

• The FDA submitted rules restricting the manufacturing, distribution, and sale of all menthol-flavored

Transcript Highlights:

• We do work with the FDA, and food safety and public safety are our number one priority at the Department

Keywords: 909, all

Transcript Highlights:

• But we are living in a tremendous time, and we’ve seen new treatments approved by the FDA, which is an
• We now have three FDA-approved medications for severe alopecia areata, with severe being defined as loss
• millions of dollars into sickle cell, and with... ...in the last two or three years, in regard to what the FDA
• that, you know, there are treatment options that are more... ...available and in the process of being FDA

Keywords: 995, all

Summary: The hearing opened with the Senate and House chairs of the Joint Committee on Financial Services explaining that the day’s agenda would focus on health insurance and other insurance matters, with a large number of witnesses and a request for brief testimony. Legislators were taken out of order to accommodate their schedules, and the committee heard testimony on several bills, including coverage for hair prostheses for alopecia (H. 1223/S. 832), medically necessary oral and dental care for head and neck cancer survivors (H. 1258), modernizing fertility and family-building coverage (H. 715/H. 1190 and related bills), coverage for prosthetic devices to support physical activity for people with limb loss (the “So Everybody Can Move” bill), remediation coverage for home heating oil releases (S. 813/H. 1302), and expanded access to physical therapy for Ehlers-Danlos syndrome (H. 1170). A separate bill on sickle cell care and registry development (S. 788) was also discussed by Senator Liz Miranda. Witnesses largely offered personal stories and expert testimony in support of the bills. Advocates for alopecia coverage described the medical and emotional impact of hair loss, the high cost of quality wigs, and the argument that scalp and facial hair prostheses should be treated like other medically necessary prosthetics. Cancer survivors and supporters of H. 1258 said oral and dental care after head and neck cancer treatment is a quality-of-life issue and often not covered despite major out-of-pocket costs. Fertility specialists, LGBTQ+ advocates, and legislators supporting the modern family-building bills said the current infertility definition is outdated and discriminatory, excluding same-sex couples, people needing donors or gestational carriers, and others with medical barriers to conception. For the limb-loss bill, parents and adults with prosthetic needs stressed that activity-specific prostheses are essential for children and adults to run, swim, play sports, and stay healthy, but are often excluded from coverage. The home heating oil testimony focused on the financial devastation caused by residential oil spills and the need to make spill coverage automatic in homeowners policies. Environmental professionals and homeowners described cleanup costs ranging from tens of thousands to hundreds of thousands of dollars, the strict liability homeowners face, and the fact that many policyholders do not know the rider exists. The insurance industry testified in opposition to the mandatory-coverage approach, arguing for clearer distinctions between first- and third-party coverage, risk-mitigation standards, a delayed effective date, and more emphasis on education and notification rather than mandates. Committee members pressed the industry witness on why agents do not routinely tell customers about the rider and suggested that the issue may require broader disclosure by insurers, agents, and fuel dealers. No votes were taken during the hearing; the committee heard testimony and discussed possible compromise language and future action.

Transcript Highlights:

• So, most medications that have instructions printed have been through FDA trials and Looked at different
• Recognize, to clarify, well, the difference is they go Through FDA trials because there are different
• And I would respond back by saying That ivermectin over the counter also has gone through FDA trials
• and is FDA approved.

Bills: HB4420, HB3974, HB3016, HB3062, HB3021, HB3145, HB4128, HB3131, HB3015, HB3472, HB3453, HB1638, HB4126, HB2696, HB2710, HB3552, HB3031, HB3544, HB3521, HB4490, HB4488, HB1746, HJR1069, HB4428, HB4429, HB1170, HB3538, HB4124, HB3904, HB4106, HB2999, HB3982, HJR1077, HB3464, HB2588, HB3462, HB4440, HB3674, HB3345, HJR1067, HB4326, HB4331, HB4337, HB4338, HB4359, HB4392, HB3557, HJR1076, HB4003, HB3495, HB3497, HB3501, HB3505, HB3749, HB3011, HB4336, HB4346, HJR1087, HB3240, HB3647, HB3796, HB3969, HB3972, HB3983, HB3984, HB3989, HB3383, HB3130, HB4358, HB3327, HJR1055, HB3386, HJR1089, HB3087, HB2970, HB3314, HB4129, HB4199

Keywords: reading, intervention, literacy, education, third grade retention, teacher training, funding, Strong Readers Act, tort claims, inmate housing, government immunity, public trust, private prison, emergency legislation, vision screening, binocular vision, kindergarten, elementary education, health, firearm rights

Transcript Highlights:

• Third, it ensures that any FDA-approved medications prescribed by the treating physician are administered
• c><00:05:55.560> ensures<00:05:56.040> that<00:05:56.160> any<00:05:56.360> FDA
• Third, it it ensures that any FDA Third, it it ensures that any FDA approved<00:05:57.440> medications

Keywords: 1191, senate, all

Transcript Highlights:

• These measures inspire nationwide changes with the FDA subsequently banning two of these chemicals and
• Scarlet letter The bill then is structured the bill currently drives these FDA improved ingredients to
• And in fact, after we passed… The California Food Safety Act that banned those four ingredients, the FDA
• to do with something called the GRASS loophole, the Generally Recognized as Safe loophole, that the FDA

Keywords: 988, house, all

Transcript Highlights:

• If the governor's transmittal letter, he suggests that the FDA, the federal, the, are what the people
• Number two, the argument I've laid out, Senator, for why we believe the FDA does not apply, is one argument
• First, the governor's rationale fails because even if the FDA is deemed unconstitutional, there is no

Keywords: 999, senate, all

Transcript Highlights:

• If the governor's transmittal letter, he suggests that the FDA—the federal, the—are what the people voted
• Number two, the argument I've laid out, Senator, for why we believe the FDA does not apply, is one argument
• First, the governor's rationale fails because even if the FDA is deemed unconstitutional, there is no

Summary: The Committee on Rules met with a quorum and heard a Governor’s Office presentation on a proposed congressional reapportionment map. The governor’s counsel argued that mid-cycle congressional redistricting is legally permissible, that race should not be considered at all in drawing districts, and that the Florida Fair Districts provisions are inconsistent with federal equal protection law and should be treated as non-severable. The presentation also discussed the pending U.S. Supreme Court case Louisiana v. Callais and the Florida Supreme Court’s Black Voters Matter decision as part of the legal rationale for the map. Jason Parada, who said he drew the map alone, described the map as based on 2020 census block data, with county-level population estimates used only as a guide to identify faster-growing areas. He said the plan keeps 48 counties and 382 municipalities whole, has compactness scores similar to the current benchmark map, and uses traditional geographic and political boundaries such as roads, railways, county lines, and municipal lines. He walked through regional changes, emphasizing a race-neutral redesign that significantly altered South Florida, including changes to districts in Palm Beach, Broward, Miami-Dade, and the Everglades, while leaving several northern districts largely unchanged. Members questioned the witnesses extensively about the legal theory, the use of partisan data, the role of race, population growth, and the timing and review of the map. The witnesses said partisan data was considered along with other traditional redistricting criteria, but race was not used. They also said they could not speak to who else reviewed the map beyond EOG staff and counsel. Several senators raised concerns about the map’s compactness, county and city splits, the apparent partisan effects, and the fact that the map was released shortly before the special session. No vote or final action on the map was taken during the portion of the meeting provided.